Amarin Corp Plc (AMRN)

[ggwpq]

PFE's dropping of its bid for AZN is a clear positive for AMRN, IMO. According to WSJ, "Mr. Read said Pfizer would look at deals that would strengthen its core areas, including vaccines, cancer, inflammation, heart disease and pain. He said Pfizer was open to transactions of all sizes and was interested in deals that would bulk up the company's two main segments: new, patent-protected medicines and older products that are losing or have lost exclusivity."

I believed PFE hired an Omega-3 expert few months ago. It is clearly interested in what Amarin is working on.